Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

100%(4 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_3

20%

Ph phase_4

20%

Ph not_applicable

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated120%

completed480%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_3

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

NCT03785366

completed

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

NCT02067663

terminatednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT03785366Phase 3

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

Completed

NCT02067663

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Completed

NCT02169869Not Applicable

Immediate Postplacental IUD Insertion

Terminated

NCT01299116Phase 4

Long-Acting Reversible Contraception

Completed

NCT02414919

Duration of Use of Highly Effective Reversible Contraception

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5